Preop RT May Boost Response to Chemo-Immunotherapy in High-Risk Early Breast Cancer

(MedPage Today) — SAN ANTONIO — Preoperative radiation therapy (RT) combined with the PD-1 inhibitor pembrolizumab (Keytruda) significantly increased immune activation and tumor response in hormone receptor-positive (HR+)/HER2-negative node-positive breast cancer…